UPDATE: JPMorgan Downgrades Healthcare Trust of America (HTA) to Neutral

December 21, 2020 3:36 AM EST
Get Alerts HTA Hot Sheet
Price: $30.64 -0.2%

Rating Summary:
    11 Buy, 8 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 7 | Down: 15 | New: 24
Trade Now! 
Join SI Premium – FREE
(Updated - December 21, 2020 4:32 AM EST)

(updating comment)

JPMorgan analyst Michael W. Mueller downgraded Healthcare Trust of America (NYSE: HTA) from Overweight to Neutral with a price target of $29.00.

The analyst comments "We are moving our rating on HTA from Overweight to Neutral. We view today’s action as simply resetting some of our ratings (in our relative rating system) to reflect a more favorable view of some stocks that have been disproportionately impacted by COVID-19 headwinds. As it relates to HTA’s business, we continue to anticipate stable core growth over the near-to-intermediate term, supplemented by acquisitions and some development. For income-oriented investors, the stock offers a dividend yield that is ~125 bps higher than that of the overall REIT group."

For an analyst ratings summary and ratings history on Healthcare Trust of America click here. For more ratings news on Healthcare Trust of America click here.

Shares of Healthcare Trust of America closed at $27.34 yesterday.


You May Also Be Interested In





Related Categories

Analyst Comments, Downgrades

Related Entities

JPMorgan